We compared invasive cervical cancer (ICC) incidence rates in Europe, South Africa, Latin and North America among women living with HIV who initiated antiretroviral therapy (ART) between 1996 and 2014. We analyzed cohort data from the International Epidemiology Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. We used flexible parametric survival models to determine regional ICC rates and risk factors for incident ICC. We included 64,231 women from 45 countries. During 320,141 person-years (pys), 356 incident ICC cases were diagnosed (Europe 164, South Africa 156, North America 19 and Latin America 17). Raw ICC incidence rates per 100,000 pys were 447 in South Africa (95% confidence interval [CI]: 382-523), 136 in Latin America (95% CI: 85-219), 76 in North America (95% CI: 48-119) and 66 in Europe (95% CI: 57-77). Compared to European women ICC rates at 5 years after ART initiation were more than double in Latin America (adjusted hazard ratio [aHR]: 2.43, 95% CI: 1.27-4.68) and 11 times higher in South Africa (aHR: 10.66, 95% CI: 6.73-16.88), but similar in North America (aHR: 0.79, 95% CI: 0.37-1.71). Overall, ICC rates increased with age (>50 years vs. 16-30 years, aHR: 1.57, 95% CI: 1.03-2.40) and lower CD4 cell counts at ART initiation (per 100 cell/μl decrease, aHR: 1.25, 95% CI: 1.15-1.36). Improving access to early ART initiation and effective cervical cancer screening in women living with HIV should be key parts of global efforts to reduce cancer-related health inequities.

Cervical cancer risk in women living with HIV across four continents: A multicohort study / Rohner, E.; Butikofer, L.; Schmidlin, K.; Sengayi, M.; Maskew, M.; Giddy, J.; Taghavi, K.; Moore, R. D.; Goedert, J. J.; Gill, M. J.; Silverberg, M. J.; D'Souza, G.; Patel, P.; Castilho, J. L.; Ross, J.; Sohn, A.; Bani-Sadr, F.; Taylor, N.; Paparizos, V.; Bonnet, F.; Verbon, A.; Vehreschild, J. J.; Post, F. A.; Sabin, C.; Mocroft, A.; Dronda, F.; Obel, N.; Grabar, S.; Spagnuolo, V.; Quiros-Roldan, E.; Mussini, C.; Miro, J. M.; Meyer, L.; Hasse, B.; Konopnicki, D.; Roca, B.; Barger, D.; Clifford, G. M.; Franceschi, S.; Egger, M.; Bohlius, J.. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 146:3(2020), pp. 601-609. [10.1002/ijc.32260]

Cervical cancer risk in women living with HIV across four continents: A multicohort study

Mussini C.;
2020

Abstract

We compared invasive cervical cancer (ICC) incidence rates in Europe, South Africa, Latin and North America among women living with HIV who initiated antiretroviral therapy (ART) between 1996 and 2014. We analyzed cohort data from the International Epidemiology Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. We used flexible parametric survival models to determine regional ICC rates and risk factors for incident ICC. We included 64,231 women from 45 countries. During 320,141 person-years (pys), 356 incident ICC cases were diagnosed (Europe 164, South Africa 156, North America 19 and Latin America 17). Raw ICC incidence rates per 100,000 pys were 447 in South Africa (95% confidence interval [CI]: 382-523), 136 in Latin America (95% CI: 85-219), 76 in North America (95% CI: 48-119) and 66 in Europe (95% CI: 57-77). Compared to European women ICC rates at 5 years after ART initiation were more than double in Latin America (adjusted hazard ratio [aHR]: 2.43, 95% CI: 1.27-4.68) and 11 times higher in South Africa (aHR: 10.66, 95% CI: 6.73-16.88), but similar in North America (aHR: 0.79, 95% CI: 0.37-1.71). Overall, ICC rates increased with age (>50 years vs. 16-30 years, aHR: 1.57, 95% CI: 1.03-2.40) and lower CD4 cell counts at ART initiation (per 100 cell/μl decrease, aHR: 1.25, 95% CI: 1.15-1.36). Improving access to early ART initiation and effective cervical cancer screening in women living with HIV should be key parts of global efforts to reduce cancer-related health inequities.
2020
19-giu-2019
146
3
601
609
Cervical cancer risk in women living with HIV across four continents: A multicohort study / Rohner, E.; Butikofer, L.; Schmidlin, K.; Sengayi, M.; Maskew, M.; Giddy, J.; Taghavi, K.; Moore, R. D.; Goedert, J. J.; Gill, M. J.; Silverberg, M. J.; D'Souza, G.; Patel, P.; Castilho, J. L.; Ross, J.; Sohn, A.; Bani-Sadr, F.; Taylor, N.; Paparizos, V.; Bonnet, F.; Verbon, A.; Vehreschild, J. J.; Post, F. A.; Sabin, C.; Mocroft, A.; Dronda, F.; Obel, N.; Grabar, S.; Spagnuolo, V.; Quiros-Roldan, E.; Mussini, C.; Miro, J. M.; Meyer, L.; Hasse, B.; Konopnicki, D.; Roca, B.; Barger, D.; Clifford, G. M.; Franceschi, S.; Egger, M.; Bohlius, J.. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 146:3(2020), pp. 601-609. [10.1002/ijc.32260]
Rohner, E.; Butikofer, L.; Schmidlin, K.; Sengayi, M.; Maskew, M.; Giddy, J.; Taghavi, K.; Moore, R. D.; Goedert, J. J.; Gill, M. J.; Silverberg, M. J.; D'Souza, G.; Patel, P.; Castilho, J. L.; Ross, J.; Sohn, A.; Bani-Sadr, F.; Taylor, N.; Paparizos, V.; Bonnet, F.; Verbon, A.; Vehreschild, J. J.; Post, F. A.; Sabin, C.; Mocroft, A.; Dronda, F.; Obel, N.; Grabar, S.; Spagnuolo, V.; Quiros-Roldan, E.; Mussini, C.; Miro, J. M.; Meyer, L.; Hasse, B.; Konopnicki, D.; Roca, B.; Barger, D.; Clifford, G. M.; Franceschi, S.; Egger, M.; Bohlius, J.
File in questo prodotto:
File Dimensione Formato  
ijc.32260.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 621.39 kB
Formato Adobe PDF
621.39 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1184745
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 32
social impact